Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Myovant Sciences (MYOV)
NYSE:MYOV
Holding MYOV?
Track your performance easily
MYOV Stock Chart & Stats
Day’s Range$26.98 - $27
52-Week Range― - ―
Previous Close$26.99
Volume2.26M
Average Volume (3M)N/A
Market Cap
$2.62B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Myovant Sciences News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MYOV FAQ
What was Myovant Sciences’s price range in the past 12 months?
Currently, no data Available
What is Myovant Sciences’s market cap?
Currently, no data Available
When is Myovant Sciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Myovant Sciences’s earnings last quarter?
Currently, no data Available
Is Myovant Sciences overvalued?
According to Wall Street analysts Myovant Sciences’s price is currently Overvalued.
Does Myovant Sciences pay dividends?
Myovant Sciences does not currently pay dividends.
What is Myovant Sciences’s EPS estimate?
Myovant Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Myovant Sciences have?
Currently, no data Available
What happened to Myovant Sciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Myovant Sciences?
Among the largest hedge funds holding Myovant Sciences’s share is Gotham Asset Management LLC. It holds Myovant Sciences’s shares valued at N/A.
---
Myovant Sciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Myovant Sciences
Myovant Sciences, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing therapies for the treatment of women's health and endocrine diseases. The company's product includes relugolix, which is an oral, once-daily and small molecule that acts as a GnRH receptor antagonist. It also develops MVT-602 a kisspeptin agonist for the treatment of female infertility. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom.
---
MYOV Stock 12 Month Forecast
Average Price Target
―Akebia Therapeutics
―
Axsome Therapeutics
―
Bellicum Pharmaceuticals
―
Aclaris Therapeutics
―
---